Jiabao Zhou

机构：Central South University, Second Xiangya Hospital of Central South University · ORCID：0009-0004-8547-9491

发表论文 13 篇 · 总被引 181 次 · h-index 6

代表论文

• Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046—a systematic analysis of the Global Burden of Disease Study 2021 (2025 · EP Europace · 被引 80)
• Shizhifang ameliorates pyroptosis of renal tubular epithelial cells in hyperuricemia through inhibiting NLRP3 inflammasome (2023 · Journal of Ethnopharmacology · 被引 28)
• GTS-21 alleviates sepsis-induced atrial fibrillation susceptibility by modulating macrophage polarization and Neuregulin-1 secretion (2025 · International Immunopharmacology · 被引 21)
• Association between the life's essential 8 health behaviors and prognosis in patients with advanced cardiovascular-kidney-metabolic syndrome (2025 · European Journal of Preventive Cardiology · 被引 18)
• Endothelial injury and inflammation in patients with hyperuricemic nephropathy at chronic kidney disease stages 1-2 and 3-4 (2022 · World Journal of Clinical Cases · 被引 7)
• Network pharmacology, molecular docking, combined with experimental verification to explore the role and mechanism of shizhifang decoction in the treatment of hyperuricemia (2024 · Heliyon · 被引 6)